Examples of using Relapsed in English and their translations into Vietnamese
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
In 2004, a Phase I/II study involved 17 patients at 2 locations with relapsed, refractory poor-risk AML with FLT3 mutations; this study demonstrated effective FLT3 inhibition by lestaurtinib.
In addition, MOR208 is currently being investigated in patients with relapsed/refractory CLL/SLL after discontinuation of a prior Bruton tyrosine kinase(BTK) inhibitor therapy(e.g. ibrutinib) in combination with idelalisib or venetoclax.
Patients who relapsed after treatment were re-treated for a longer period of 6 months, with one patient receiving 12 months of treatment,
Brentuximab has been approved in 50 countries to treat patients with relapsed or treatment-resistant Hodgkin lymphoma, and received U.S Food
Those of us who have relapsed after such an episode often try to go to as many meetings as we can- some of us go to a meeting every day for several years.
Relapsed, without criminal record remission but deliberately committed offenses, regardless of whether such offenses are less serious offenses,
Those of us who have relapsed after such an episode often try to go to as many meetings as we can-some of us go to a meeting every day for several years.
In Brazil, colloidal amphotericin B with sodium cholesteryl sulfate in a dose of 2 mg/kg daily for 5 days produced cures in 10 patients although 1 subsequently relapsed.
Bond also relapsed into silence and occupied himself with his own gloomy thoughts.”.
combined modality therapy using targeted therapeutic agents and cellular therapy for the treatment of patients with relapsed or refractory haematological malignancies.
In a Phase II trial(004), carfilzomib had a 53% overall response rate among patients with relapsed and/or refractory multiple myeloma who had not previously received bortezomib.
Eighty-nine percent of subjects tried to abstain from kratom in the past but all had relapsed due to withdrawal symptoms, such as insomnia, nausea, vomiting, diarrhea, muscle pains
acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma that has not responded to or has relapsed following treatment with at least two chemotherapy regimens.[2] It was later
in the U.S. and Europe for treating relapsed multiple myeloma and mantle cell lymphoma.[1][2][3]
under very specific conditions: For people aged three to 25 with relapsed ALL that has not responded to conventional therapy.
known as the ASPIRE trial, comparing carfilzomib, lenalidomide and dexamethasone versus lenalidomide and dexamethasone in patients with relapsed multiple myeloma is ongoing.[25]
post-polycythemia vera or post-essential thrombocythemia myelofibrosis(post-PV/ET MF),[4] as well as a treatment for relapsed or refractory metastatic pancreatic ductal adenocarcinoma(in combination with capecitabine and oxaliplatin).[5].
They followed the patients for 12 months and compared vitamin D levels in patients who stayed in remission with those who relapsed and found the median baseline vitamin D level was lower in patients who relapsed than those who did not.
In July 2014, the FDA and EMA granted idelalisib approval to treat different types of leukemia.[1][2] The FDA is also granted approval for idelalisib to treat patients with relapsed follicular B-cell non-Hodgkin lymphoma and relapsed small lymphocytic lymphoma.
Pralatrexate(brand name Folotyn) is an anti-cancer therapy.[1] It is the first drug approved as a treatment for patients with relapsed or refractory peripheral T-cell lymphoma, or PTCL[2]- a biologically diverse group of aggressive blood cancers that have a poor prognosis.[2].